Blenrep for Multiple Myeloma Withdrawn From US Market Blenrep for Multiple Myeloma Withdrawn From US Market

The manufacturer is pulling the drug from the market at the request of the FDA following disappointing results from a large phase 3 confirmatory trial.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news